Voisard Asset Management Group, Inc. Iovance Biotherapeutics, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $205 Billion
- Q2 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 273 shares of IOVA stock, worth $2,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273
Previous 273
-0.0%
Holding current value
$2,822
Previous $4.05 Million
45.87%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
323Shares Held
239MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$268 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$268 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$248 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$219 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$131 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.63B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...